AFTER BREAST CANCER DIAGNOSIS C.I.C.

Company limited by guarantee

Company Registration Number:
11174173 (England and Wales)

Unaudited statutory accounts for the year ended 30 January 2025

Period of accounts

Start date: 31 January 2024

End date: 30 January 2025

AFTER BREAST CANCER DIAGNOSIS C.I.C.

Contents of the Financial Statements

for the Period Ended 30 January 2025

Balance sheet
Additional notes
Balance sheet notes
Community Interest Report

AFTER BREAST CANCER DIAGNOSIS C.I.C.

Balance sheet

As at 30 January 2025

Notes 2025 2024


£

£
Fixed assets
Intangible assets:   0 0
Tangible assets: 3 988 1,474
Investments:   0 0
Total fixed assets: 988 1,474
Current assets
Stocks:   0 0
Debtors:   0 0
Cash at bank and in hand: 34,134 31,116
Investments:   0 0
Total current assets: 34,134 31,116
Prepayments and accrued income: 0 0
Creditors: amounts falling due within one year:   0 0
Net current assets (liabilities): 34,134 31,116
Total assets less current liabilities: 35,122 32,590
Accruals and deferred income: ( 36,872 ) ( 33,427 )
Total net assets (liabilities): (1,750) (837)
Members' funds
Profit and loss account: (1,750) ( 837)
Total members' funds: ( 1,750) (837)

The notes form part of these financial statements

AFTER BREAST CANCER DIAGNOSIS C.I.C.

Balance sheet statements

For the year ending 30 January 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen not to file a copy of the company's profit and loss account.

This report was approved by the board of directors on 30 October 2025
and signed on behalf of the board by:

Name: J Talyor
Status: Director

The notes form part of these financial statements

AFTER BREAST CANCER DIAGNOSIS C.I.C.

Notes to the Financial Statements

for the Period Ended 30 January 2025

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

AFTER BREAST CANCER DIAGNOSIS C.I.C.

Notes to the Financial Statements

for the Period Ended 30 January 2025

  • 2. Employees

    2025 2024
    Average number of employees during the period 1 1

AFTER BREAST CANCER DIAGNOSIS C.I.C.

Notes to the Financial Statements

for the Period Ended 30 January 2025

3. Tangible assets

Land & buildings Plant & machinery Fixtures & fittings Office equipment Motor vehicles Total
Cost £ £ £ £ £ £
At 31 January 2024 2,583 2,583
Additions
Disposals
Revaluations
Transfers
At 30 January 2025 2,583 2,583
Depreciation
At 31 January 2024 1,109 1,109
Charge for year 486 486
On disposals
Other adjustments
At 30 January 2025 1,595 1,595
Net book value
At 30 January 2025 988 988
At 30 January 2024 1,474 1,474

COMMUNITY INTEREST ANNUAL REPORT

AFTER BREAST CANCER DIAGNOSIS C.I.C.

Company Number: 11174173 (England and Wales)

Year Ending: 30 January 2025

Company activities and impact

The companies aim is to support people that have been diagnosed, being treated for, or are recovering from cancer. Throughout the year a number of 2-3-day events are organised to bring together people affected for support, advice and companionship. The events focus on is for people to experience and receive motivation, exercise, strength, support, help, share experiences, meet new friends, get time away from day to day normal life and get out in the fresh air. All this is to help and support people through their cancer journey. The company aims to receive income from grants which will fully fund or at least subsidise the cost to attendees.

Consultation with stakeholders

Stakeholders are consulted by means of feedback from sources such as twitter support groups and also consulting relevantly qualified professionals such as doctors and nurses and their views are listened to and acted upon.

Directors' remuneration

The director was paid £6,000 during the year.

Transfer of assets

No transfer of assets other than for full consideration

This report was approved by the board of directors on
30 October 2025

And signed on behalf of the board by:
Name: J Taylor
Status: Director